Evaluation of early clinical failure criteria for gram-negative bloodstream infections

被引:25
|
作者
Rac, H. [1 ]
Gould, A. P. [2 ]
Bookstaver, P. B. [1 ,3 ]
Justo, J. A. [1 ,3 ]
Kohn, J. [3 ]
Al-Hasan, M. N. [4 ,5 ]
机构
[1] Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA
[2] Novant Hlth, Charlotte, NC USA
[3] Prisma Hlth Richland, Columbia, SC USA
[4] Univ South Carolina, Sch Med, Columbia, SC 29208 USA
[5] Palmetto Hlth Univ, South Carolina Med Grp, Columbia, SC USA
关键词
Antibiotics; Bacteraemia; Bloodstream infection; Clinical failure; Early clinical failure; Enterobacteriaceae; Gram-negative infection; Treatment response; EMPIRICAL ANTIMICROBIAL THERAPY; ENTEROBACTERIACEAE BACTEREMIA; NOSOCOMIAL INFECTIONS; BETA-LACTAMS; SCORE; ADULTS; DURATION; RISK; STRATIFICATION; CEPHALOSPORINS;
D O I
10.1016/j.cmi.2019.05.017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim was the development of early clinical failure criteria (ECFC) to predict unfavourable outcomes in patients with Gram-negative bloodstream infections (GN-BSI). Methods: Adults with community-onset GN-BSI who survived hospitalization for >= 72 hr at Prisma Health-Midlands hospitals in Columbia, SC, USA from January 1, 2010 to June 30, 2015 were identified. Multivariable logistic regression was used to examine the association between clinical variables between 72 and 96 hr after GN-BSI and unfavourable outcomes (28-day mortality or hospital length of stay >14 days from GN-BSI onset). Results: Among 766 patients, 225 (29%) had unfavourable outcomes. After adjustments for Charlson Comorbidity Index and appropriateness of empirical antimicrobial therapy in multivariable model, predictors of unfavourable outcomes included systolic blood pressure <100 mmHg or vasopressor use (adjusted odds ratio (aOR) 1.8, 95% confidence interval (CI) 1.2-2.9), heart rate >100 beats/minute (aOR 1.7, 95% CI 1.1-2.5), respiratory rate >= 22 breaths/minute or mechanical ventilation (aOR 2.1, 95% CI 1.4-3.3), altered mental status (aOR 4.5, 95% CI 2.8-7.1), and white blood cell count >12 000/mm(3) (aOR 2.7, 95% CI 1.8-4.1) between 72 and 96 hr after index GN-BSI. Area under receiver operating characteristic curve of ECFC model in predicting unfavourable outcomes was 0.77 (0.84 and 0.71 in predicting 28-day mortality and prolonged hospitalization, respectively). Conclusions: Risk of 28-day mortality or prolonged hospitalization can be estimated between 72 and 96 hr after GN-BSI using ECFC. These criteria may have clinical utility in management of GN-BSI and may improve methodology of future investigations assessing response to antimicrobial therapy based on a standard evidence-based definition of early clinical failure. (c) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [21] Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections
    Leli, Christian
    Ferranti, Marta
    Moretti, Amedeo
    Al Dhahab, Zainab Salim
    Cenci, Elio
    Mencacci, Antonella
    DISEASE MARKERS, 2015, 2015
  • [22] Optimizing empiric therapy for Gram-negative bloodstream infections in children
    Chao, Y.
    Reuter, C.
    Kociolek, L. K.
    Patel, R.
    Zheng, X.
    Patel, S. J.
    JOURNAL OF HOSPITAL INFECTION, 2018, 99 (02) : 145 - 147
  • [23] Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification
    Esterly, John S.
    Wagner, Jamie
    McLaughlin, Milena M.
    Postelnick, Michael J.
    Qi, Chao
    Scheetz, Marc H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) : 4885 - 4890
  • [24] A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections
    Berinson, Benjamin
    Davies, Emma
    Torpner, Jessie
    Flinkfeldt, Linnea
    Fernberg, Jenny
    Aman, Amanda
    Bergqvist, Johan
    Ohrn, Hakan
    Angstrom, Jonas
    Johansson, Cecilia
    Jader, Klara
    Andersson, Helena
    Ghaderi, Ehsan
    Rolf, Maria
    Sundqvist, Martin
    Rohde, Holger
    Fernandez-Zafra, Teresa
    Malmberg, Christer
    JOURNAL OF CLINICAL MICROBIOLOGY, 2024, 62 (10)
  • [25] Could an early cholecystectomy pathway reduce the incidence of gram-negative bloodstream infections in our trust?
    Majeed, Mustafa
    Ward, Harry
    Wade, Cian
    Butcher, Lisa
    Soonawalla, Zahir
    Bond-Smith, Giles
    BRITISH JOURNAL OF SURGERY, 2020, 107 : 33 - 33
  • [26] Impact of body mass index on clinical outcomes in patients with gram-negative bacteria bloodstream infections
    Lizza, Bryan D.
    Rhodes, Nathaniel J.
    Esterly, John S.
    Toy, Carolyn
    Lopez, Jenna
    Scheetz, Marc H.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (9-10) : 671 - 676
  • [27] Differences between bloodstream infections involving gram-positive and gram-negative anaerobes
    Cobo, Fernando
    Perez-Carrasco, Virginia
    Rodriguez-Granger, Javier
    Sampedro-Martinez, Antonio
    Garcia-Salcedo, Antonio
    Navarro-Mari, Jose Maria
    ANAEROBE, 2023, 81
  • [28] CLINICAL-EVALUATION OF TICARCILLIN IN AEROBIC OR ANAEROBIC GRAM-NEGATIVE INFECTIONS
    LIMSON, BM
    LANSANG, MA
    PHILIPPINE JOURNAL OF INTERNAL MEDICINE, 1983, 21 (02): : 100 - 102
  • [29] Impact of rapid susceptibility testing on antimicrobial therapy and clinical outcomes in Gram-negative bloodstream infections
    Anton-Vazquez, Vanesa
    Suarez, Cristina
    Planche, Timothy
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (03) : 771 - 781
  • [30] Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections
    Nelson, Avery N.
    Justo, Julie Ann
    Bookstaver, P. Brandon
    Kohn, Joseph
    Albrecht, Helmut
    Al-Hasan, Majdi N.
    INFECTION, 2017, 45 (05) : 613 - 620